Swiss drugmaker Novartis on Sunday stated it agreed to accumulate U.S. biotech agency Avidity Biosciences for about $12 billion in…
Browsing: Biosciences
Anthem Biosciences IPO: The three-day subscription for the preliminary public providing (IPO) of Anthem Biosciences Restricted will open on July…
IPO Itemizing on July 21: Anthem Biosciences Restricted will make its debut on NSE (Nationwide Inventory Alternate) and BSE (Bombay…
Anthem Biosciences IPO: Following the shut of the subscription of preliminary public providing (IPO) of Anthem Biosciences Restricted, all eyes…
Need to keep on high of the science and politics driving biotech in the present day? Join to get our biotech e-newsletter…
Merck has agreed to purchase Prometheus Biosciences for $10.8bn because the US drugmaker bolsters it pipeline forward of the potential…